首页> 外文期刊>Toxicon: An International Journal Devoted to the Exchange of Knowledge on the Poisons Derived from Animals, Plants and Microorganisms >A functional and thromboelastometric-based micromethod for assessing crotoxin anticoagulant activity and antiserum relative potency against Crotalus durissus terrificus venom
【24h】

A functional and thromboelastometric-based micromethod for assessing crotoxin anticoagulant activity and antiserum relative potency against Crotalus durissus terrificus venom

机译:用于评估曲屈抗凝血活性和抗血清抗菌性毒素的官能和血管紧节动力测定的微型方法

获取原文
获取原文并翻译 | 示例
       

摘要

The assessment of the capacity of antivenoms to neutralize the lethal activity of snake venoms still relies on traditional rodent in vivo lethality assay. ED50 and LD50 assays require large quantities of venoms and antivenoms, and besides leading to animal suffering. Therefore, in vitro tests should be introduced for assessing antivenom neutralizing capacity in intermediary steps of antivenom production. This task is facilitated when one key lethal toxin is identified. A good example is crotoxin, a P-neurotoxin phospholipase A(2)-like toxin that presents anticoagulant activity in vitro and is responsible for the lethality of venoms of Crotalus durissus snakes. By using rotational thromboelastometry, we reported recently one sensitive coagulation assay for assessing relative potency of the anti-bothropic serum in neutralizing procoagulant activity of Bothrops jararaca venom upon recalcified factor-XII-deficient chicken plasma samples (CPS). In this study, we stablished conditions for determining relative potency of four batches of the anti-crotalic serum (ACS) (antagonist) in inactivating crotoxin anticoagulant activity in CPS (target) simultaneously treated with one classical activator of coagulation (agonists). The correlation coefficient (r) between values related the ACS potency in inactivating both in vitro crotoxin anticoagulant activity and the in vivo lethality of whole venom (ED50) was 0.94 (p value & 0.05). In conclusion, slowness in spontaneous thrombin/fibrin generation even after recalcification elicit time lapse sufficient for elaboration of one dose-response curve to pro-or anti-coagulant agonists in CPS. We propose this methodology as an alternative and sensitive assay for assessing antivenom neutralizing ability in plasma of immunized horses as well as for in-process quality control. (C) 2018 Elsevier Ltd. All rights reserved.
机译:评估抗静物中和蛇毒液的致死活性的能力仍然依赖于体内致死性测定的传统啮齿动物。 ED50和LD50测定需要大量的毒液和抗静电子,并且除了导致动物痛苦。因此,应引入体外试验,用于评估抗静电制备中间步骤中的抗永动脉中和能力。当确定一个关键的致命毒素时,就会促进此任务。一个很好的例子是曲棍蛋毒,一种p-神经毒素磷脂酶A(2) - 染色毒素,其在体外呈现抗凝血活性,并负责克罗塔属Durissus snakes的静脉曲化。通过使用旋转血栓间质测定法,我们最近报道了一种敏感的凝血测定,用于评估抗玻孔血清在重新计算因子 - XII缺乏鸡等离子体样品(CPS)上与βjararaca毒液的中和术治疗的相对效力。在该研究中,我们在同时用一种经典活化剂(激动剂)同时处理CPS(靶标)中的四批抗词学血清(ACS)(ACS)(拮抗剂)中的四批抗词素血清(ACS)(ACS)(拮抗剂)的相对效力的条件。值之间的相关系数(R)相关的ACS效力在体外串联抗凝血活性和整个毒液(ED50)的体内致命性中偶联的ICS效力为0.94(P值& 0.05)。总之,即使重新计算出来的血浆/纤维蛋白生成中的缓慢也足以使一个剂量 - 反应曲线拟合到CPS中的抗凝血剂曲线中的诱导曲线。我们将这种方法提出作为评估免疫马等血浆中的抗动子中和能力的替代和敏感的测定,以及用于内部质量控制。 (c)2018年elestvier有限公司保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号